Literature DB >> 19847014

Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation.

O Adeyi1, S E Fischer, M Guindi.   

Abstract

The spectrum of diseases encountered in post-transplant liver pathology biopsies is broad. In this review, these have been divided as belonging to one of three categories: (1) new-onset/de novo post-transplant abnormalities (early and late), (2) rejection, and (3) recurrence of original disease. The clinical and pathological features of the entities making up each category, with the relevant differential diagnosis and overlaps between and within these groups, are discussed and illustrated. Recurrent or de novo neoplasms make up a fourth category not included in this review. Early new-onset conditions are mostly related to surgical complications, donor factors and ischaemia to the graft. These include reperfusion/preservation injury, lipopeliosis, small-for-size-syndrome, biliary sludge syndrome and hepatic artery thrombosis. The various forms of rejection (cellular, chronic, antibody-mediated, and late atypical rejection) are detailed. Most chronic liver diseases can and do recur in the graft. They may display features that overlap with de novo conditions (eg, primary sclerosing cholangitis versus chronic rejection). As with most cases of allograft biopsy interpretation, accurate diagnosis rests with careful correlation of histological features with clinical, imaging and laboratory findings, and often comparison with previous sequential and follow-up biopsies. Late-onset new diseases include biliary strictures, idiopathic chronic hepatitis and de novo autoimmune hepatitis, among others. This review provides a practical approach to the interpretation of these challenging biopsies. Selected difficult scenarios or conundrums are identified and discussed in the relevant sections.

Entities:  

Mesh:

Year:  2009        PMID: 19847014     DOI: 10.1136/jcp.2009.068254

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

Review 1.  [Current aspects of liver allograft pathology].

Authors:  U Drebber; M Torbenson; I Wedemeyer; H P Dienes
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

Review 2.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

Authors:  Kieron B L Lim; Hamid R Sima; M Isabel Fiel; Viktoriya Khaitova; John T Doucette; Maria Chernyiak; Jawad Ahmad; Nancy Bach; Charissa Chang; Priya Grewal; Leona Kim-Schluger; Lawrence Liu; Joseph Odin; Ponni Perumalswami; Sander S Florman; Thomas D Schiano
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

4.  High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.

Authors:  Nabiha Faisal; Khalid Mumtaz; Max Marquez; Eberhard L Renner; Leslie B Lilly
Journal:  Hepatol Int       Date:  2014-11-29       Impact factor: 6.047

Review 5.  Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Authors:  John E Eaton; Jayant A Talwalkar; Konstantinos N Lazaridis; Gregory J Gores; Keith D Lindor
Journal:  Gastroenterology       Date:  2013-07-01       Impact factor: 22.682

6.  Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies.

Authors:  Ta-Chiang Liu; Thong T Nguyen; Michael S Torbenson
Journal:  Mod Pathol       Date:  2012-07-06       Impact factor: 7.842

7.  How do we manage post-OLT redundant bile duct?

Authors:  Victor Torres; Nicholas Martinez; Gabriel Lee; Jose Almeda; Glenn Gross; Sandeep Patel; Laura Rosenkranz
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

8.  Infiltrative (sinusoidal) and hepatitic patterns of injury in acute cellular rejection in liver allograft with clinical implications.

Authors:  Iram Siddiqui; Nazia Selzner; Sara Hafezi-Bakhtiari; Max A Marquez; Oyedele A Adeyi
Journal:  Mod Pathol       Date:  2015-07-31       Impact factor: 7.842

9.  Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Danielle E Ladie; Jihee L Suh; Samuel Luebbert; Daniel G Maluf
Journal:  Transplantation       Date:  2013-11-27       Impact factor: 4.939

10.  Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies.

Authors:  K V Kanodia; A V Vanikar; P R Modi; R D Patel; K S Suthar; L K Nigam; H L Trivedi
Journal:  J Clin Diagn Res       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.